Concepedia

Author

P.S. Sears

Edimer Pharmaceuticals (United States)

Also Known As

P Sears, P. S. Sears, P. SEARS, P. Sears, P.S. Sears, PAMELA S. SEARS, Pamela S Sears, Pamela S. Sears, Pamela Sears, Pamela Suzanne Sears

150

Publications

6.9K

Citations

35

H-Index

78

Concepts

All Affiliations

Edimer Pharmaceuticals (United States)Scripps Research InstituteMerck & Co., Inc., Rahway, NJ, USA (United States)Tufts UniversityLoyola University Chicago
PS

About

P.S. Sears is an author at Edimer Pharmaceuticals (United States) specializing in medicine, biochemistry, and microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

22

2.3K

2

Natural Sciences

11

12

974

3

Engineering

6

6

253

4

Health Sciences

6

6

1K

5

Public Health

1

1

35

P.S. Sears

×

48

Publications

5.9K

Citations

34

H-Index

YearCitations

Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection

Thomas Louie, Mark A. Miller, Kathleen M. Mullane,

New England Journal of Medicine

2011

1.6K

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

Oliver A. Cornely, Derrick W. Crook, Roberto Esposito,

The Lancet Infectious Diseases

2012

739

Carbohydrate Mimetics: A New Strategy for Tackling the Problem of Carbohydrate-Mediated Biological Recognition

P.S. Sears, Chi‐Huey Wong

Angewandte Chemie International Edition

1999

510

Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections

Kathleen M. Mullane, Mark A. Miller, Karl Heinz Weiss,

Clinical Infectious Diseases

2011

236

Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure:  Correlation of Antibiotic Activity with in Vitro Inhibition of Translation

William A. Greenberg, E. Scott Priestley, P.S. Sears,

Journal of the American Chemical Society

1999

216

Probing the Specificity of Aminoglycoside−Ribosomal RNA Interactions with Designed Synthetic Analogs

Phil B. Alper, Martin Hendrix, P.S. Sears,

Journal of the American Chemical Society

1998

189

Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain

Laurica A Petrella, Susan P. Sambol, Adam Cheknis,

Clinical Infectious Diseases

2012

183

Enzymatic Glycoprotein Synthesis:  Preparation of Ribonuclease Glycoforms via Enzymatic Glycopeptide Condensation and Glycosylation

Krista Witte, P.S. Sears, Richard Martin,

Journal of the American Chemical Society

1997

164

Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes

Steven J. Sucheck, Andrew L. Wong, Kathryn M. Koeller,

Journal of the American Chemical Society

2000

137

Fidaxomicin Inhibits Spore Production in Clostridium difficile

Farah Babakhani, Laurent Bouillaut, Abraham Gomez,

Clinical Infectious Diseases

2012

123

Page 1